Related Experiment Video
Updated: Aug 16, 2026
09:49
Procedures for Rat in situ Skeletal Muscle Contractile Properties
Published on: October 15, 2011
Protease inhibitor activity in rat skeletal muscle
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie
|June 1, 1982
Summary
Muscle cytosol contains protease inhibitors that regulate protein breakdown. Their activity changes with age, fasting, and hormone treatment, affecting muscle health.
Area of Science:
- Biochemistry
- Molecular Biology
- Muscle Physiology
Background:
- Muscle protein degradation is a complex process influenced by various factors.
- Intracellular protease inhibitors play a crucial role in regulating proteolytic enzyme activity within muscle cells.
Purpose of the Study:
- To investigate the inhibitory effects of rat gastrocnemius muscle cytosol on specific proteolytic enzymes.
- To examine how ageing, fasting, and glucocorticoid hormone administration affect these inhibitory activities.
- To determine the impact of different biochemical treatments on the cytosol's inhibitory capacity.
Main Methods:
- Homogenization of rat gastrocnemius muscle to obtain cytosol fraction.
- Assaying the inhibitory activity of cytosol against rat alkaline myofibrillar protease, bovine trypsin, and bovine chymotrypsin.
- Subjecting cytosol to conditions including ageing, fasting, glucocorticoid treatment, trichloroacetic acid precipitation, heat, dialysis, and molecular sieve chromatography.
Main Results:
- Muscle cytosol inhibited the activity of all three tested proteases.
- The inhibitory effects varied significantly based on physiological conditions (ageing, fasting, hormone treatment).
- Biochemical treatments differentially altered the inhibitory capacity of the cytosol.
Conclusions:
- Intracellular protease inhibitors within muscle cytosol are key regulators of muscle protein degradation.
- The regulation of muscle protein turnover is dynamic and responsive to physiological changes.
- These findings have implications for understanding muscle wasting conditions and developing therapeutic strategies.
Related Concept Videos
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
01:21Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...